Silva's most recent trade in ClearSign Technologies Corp was a trade of 3,440 Restricted Stock Units done . Disclosure was reported to the exchange on March 31, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ClearSign Tech Corp | Gil Todd Silva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2026 | 3,440 | 123,909 | - | - | Restricted Stock Units | |
| ClearSign Tech Corp | Gil Todd Silva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2026 | 3,024 | 3,024 | - | - | Non-Statutory Stock Options | |
| ClearSign Tech Corp | Gil Todd Silva | Director | Purchase of securities on an exchange or from another person at price $ 4.36 per share. | 16 Mar 2026 | 2,000 | 2,000 (0%) | 0% | 4.4 | 8,710 | Common Stock |
| ClearSign Tech Corp | Gil Todd Silva | Director | Purchase of securities on an exchange or from another person at price $ 4.20 per share. | 16 Mar 2026 | 2,000 | 4,000 (0%) | 0% | 4.2 | 8,400 | Common Stock |
| Cencora | Silvana Battaglia | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2026 | 8,415 | 0 | - | - | Restricted Stock Units | |
| Cencora | Silvana Battaglia | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2026 | 8,415 | 27,238 (0%) | 0% | 0 | Common Stock | |
| Cencora | Silvana Battaglia | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 350.30 per share. | 11 Mar 2026 | 3,673 | 23,565 (0%) | 0% | 350.3 | 1,286,652 | Common Stock |
| Fresh Del Monte Produce Inc | Effie D. Silva | SVP, General Counsel & Secy | Sale of securities on an exchange or to another person at price $ 41.94 per share. | 09 Mar 2026 | 5,894 | 8,536 (0%) | 0% | 41.9 | 247,194 | Ordinary Shares |
| Cingulate Inc | Raul R. Silva | EVP and CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2026 | 4,526 | 6,473 | - | 0 | Common Stock | |
| Cingulate Inc | Raul R. Silva | EVP and CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 09 Mar 2026 | 1,828 | 4,645 | - | 0 | Common Stock | |
| Fresh Del Monte Produce Inc | Effie D. Silva | SVP, General Counsel & Secy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 2,109 | 4,219 | - | - | Performance Stock Units | |
| Fresh Del Monte Produce Inc | Effie D. Silva | SVP, General Counsel & Secy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 2,109 | 4,219 | - | - | Restricted Stock Units | |
| Fresh Del Monte Produce Inc | Effie D. Silva | SVP, General Counsel & Secy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 2,109 | 15,351 (0%) | 0% | 0 | Ordinary Shares | |
| Fresh Del Monte Produce Inc | Effie D. Silva | SVP, General Counsel & Secy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 2,109 | 13,242 (0%) | 0% | 0 | Ordinary Shares | |
| Fresh Del Monte Produce Inc | Effie D. Silva | SVP, General Counsel & Secy | Sale of securities on an exchange or to another person at price $ 42.28 per share. | 03 Mar 2026 | 536 | 14,430 (0%) | 0% | 42.3 | 22,662 | Ordinary Shares |
| Fresh Del Monte Produce Inc | Effie D. Silva | SVP, General Counsel & Secy | Sale of securities on an exchange or to another person at price $ 42.28 per share. | 03 Mar 2026 | 536 | 14,966 (0%) | 0% | 42.3 | 22,662 | Ordinary Shares |
| Fresh Del Monte Produce Inc | Effie D. Silva | SVP, General Counsel & Secy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 151 | 691 | - | - | Dividend Equivalent Units | |
| Fresh Del Monte Produce Inc | Effie D. Silva | SVP, General Counsel & Secy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 151 | 15,502 (0%) | 0% | 0 | Ordinary Shares | |
| Fresh Del Monte Produce Inc | Effie D. Silva | SVP, General Counsel & Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 4,976 | 4,976 | - | - | Restricted Stock Units | |
| Fresh Del Monte Produce Inc | Effie D. Silva | SVP, General Counsel & Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 4,976 | 4,976 | - | - | Performance Stock Units | |
| Fresh Del Monte Produce Inc | Effie D. Silva | SVP, General Counsel & Secy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2026 | 1,045 | 0 | - | - | Restricted Stock Units | |
| Fresh Del Monte Produce Inc | Effie D. Silva | SVP, General Counsel & Secy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2026 | 1,045 | 11,308 (0%) | 0% | 0 | Ordinary Shares | |
| Fresh Del Monte Produce Inc | Effie D. Silva | SVP, General Counsel & Secy | Sale of securities on an exchange or to another person at price $ 42.50 per share. | 02 Mar 2026 | 285 | 11,133 (0%) | 0% | 42.5 | 12,113 | Ordinary Shares |
| Fresh Del Monte Produce Inc | Effie D. Silva | SVP, General Counsel & Secy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2026 | 110 | 843 | - | - | Dividend Equivalent Units | |
| Fresh Del Monte Produce Inc | Effie D. Silva | SVP, General Counsel & Secy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2026 | 110 | 11,418 (0%) | 0% | 0 | Ordinary Shares | |
| Fresh Del Monte Produce Inc | Effie D. Silva | SVP, General Counsel & Secy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2026 | 5,189 | 5,189 | - | - | Performance Stock Units | |
| Fresh Del Monte Produce Inc | Effie D. Silva | SVP, General Counsel & Secy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2026 | 5,189 | 11,241 (0%) | 0% | 0 | Ordinary Shares | |
| Fresh Del Monte Produce Inc | Effie D. Silva | SVP, General Counsel & Secy | Sale of securities on an exchange or to another person at price $ 42.88 per share. | 01 Mar 2026 | 1,365 | 10,263 (0%) | 0% | 42.9 | 58,531 | Ordinary Shares |
| Fresh Del Monte Produce Inc | Effie D. Silva | SVP, General Counsel & Secy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2026 | 387 | 953 | - | - | Dividend Equivalent Units | |
| Fresh Del Monte Produce Inc | Effie D. Silva | SVP, General Counsel & Secy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2026 | 387 | 11,628 (0%) | 0% | 0 | Ordinary Shares | |
| Dine Brands Global Inc | Enrique Silva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2026 | 3,256 | 3,256 | - | - | Restricted Stock Units | |
| Illinois Tool Works | Guilherme de Figueiredo Silva | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2026 | 8,538 | 8,538 | - | - | Employee Stock Option | |
| Illinois Tool Works | Guilherme de Figueiredo Silva | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2026 | 598 | 2,750 (0%) | 0% | 0 | Common Stock | |
| Illinois Tool Works | Guilherme de Figueiredo Silva | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2026 | 598 | 0 | - | - | Performance Share Units (granted 2/10/23) | |
| Illinois Tool Works | Guilherme de Figueiredo Silva | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 298.51 per share. | 12 Feb 2026 | 193 | 2,557 (0%) | 0% | 298.5 | 57,612 | Common Stock |
| MoonLake Immunotherapeutics (Class A) | Jorge Santos da Silva | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2026 | 520,342 | 520,342 | - | - | Stock Option (Right to Buy) | |
| Cartesian Therapeutics Inc | Nishan de Silva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 7,800 | 7,800 | - | - | Stock Option (Right to Buy) | |
| Cartesian Therapeutics Inc | Nishan de Silva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 2,600 | 11,366 (0%) | 0% | 0 | Common Stock | |
| Cingulate Inc | Raul R. Silva | EVP and CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 6,625 | 6,625 | - | - | Stock Option (right to Buy) | |
| Cencora | Silvana Battaglia | Executive Vice President | Grant, award, or other acquisition of securities at price $ 290.74 per share. | 31 Dec 2025 | 27 | 18,823 (0%) | 0% | 290.7 | 7,850 | Common Stock |
| MoonLake Immunotherapeutics (Class A) | Jorge Santos da Silva | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Dec 2025 | 196,316 | 0 | - | - | Class C ordinary shares, par value $0.0001 per share | |
| MoonLake Immunotherapeutics (Class A) | Jorge Santos da Silva | Director, Chief Executive Officer | 19 Dec 2025 | 196,316 | 3,074,893 | - | - | Class A ordinary shares, par value $0.0001 per share | ||
| MoonLake Immunotherapeutics (Class A) | Jorge Santos da Silva | Director, Chief Executive Officer | 19 Dec 2025 | 5,836 | 0 | - | - | Common shares, par value CHF 0.10 per share, of MoonLake AG | ||
| Cencora | Silvana Battaglia | Executive Vice President | Sale of securities on an exchange or to another person at price $ 345.00 per share. | 19 Dec 2025 | 1,677 | 18,796 (0%) | 0% | 345 | 578,565 | Common Stock |
| MoonLake Immunotherapeutics (Class A) | Jorge Santos da Silva | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 15.08 per share. | 08 Dec 2025 | 130,000 | 2,948,577 | - | 15.1 | 1,960,400 | Class A ordinary shares, par value $0.0001 per share |
| MoonLake Immunotherapeutics (Class A) | Jorge Santos da Silva | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 14.49 per share. | 08 Dec 2025 | 70,000 | 2,878,577 | - | 14.5 | 1,014,300 | Class A ordinary shares, par value $0.0001 per share |
| Cencora | Silvana Battaglia | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 932 | 1,865 | - | - | Restricted Stock Units | |
| Cencora | Silvana Battaglia | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 932 | 20,879 (0%) | 0% | - | Common Stock | |
| Cencora | Silvana Battaglia | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 362.07 per share. | 20 Nov 2025 | 406 | 20,473 (0%) | 0% | 362.1 | 147,000 | Common Stock |
| Cencora | Silvana Battaglia | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 12,885 | 25,559 (0%) | 0% | 0 | Common Stock | |
| Cencora | Silvana Battaglia | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 312.53 per share. | 12 Nov 2025 | 5,612 | 19,947 (0%) | 0% | 312.5 | 1,753,918 | Common Stock |
| Cencora | Silvana Battaglia | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 2,202 | 2,202 | - | - | Restricted Stock Units | |
| Fresh Del Monte Produce Inc | Effie D. Silva | SVP, General Counsel & Secy | Sale of securities on an exchange or to another person at price $ 36.79 per share. | 07 Nov 2025 | 1,325 | 6,052 (0%) | 0% | 36.8 | 48,744 | Ordinary Shares |
| Cencora | Silvana Battaglia | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 1,265 | 0 | - | - | Restricted Stock Units | |
| Cencora | Silvana Battaglia | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 1,265 | 12,614 (0%) | 0% | - | Common Stock | |
| Cencora | Silvana Battaglia | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 1,084 | 1,085 | - | - | Restricted Stock Units | |
| Cencora | Silvana Battaglia | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2025 | 1,084 | 13,147 (0%) | 0% | - | Common Stock | |
| Cencora | Silvana Battaglia | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 360.70 per share. | 07 Nov 2025 | 551 | 12,063 (0%) | 0% | 360.7 | 198,746 | Common Stock |
| Cencora | Silvana Battaglia | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 360.70 per share. | 07 Nov 2025 | 473 | 12,674 (0%) | 0% | 360.7 | 170,611 | Common Stock |
| BioRestorative Therapies Inc | Francisco Silva | Director, VP of Research and Development | Grant, award, or other acquisition of securities at price $ 1.60 per share. | 06 Oct 2025 | 11,719 | 171,384 | - | 1.6 | 18,750 | Comon Stock |
| BioRestorative Therapies Inc | Francisco Silva | Director, VP of Research and Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Oct 2025 | 11,719 | 11,719 | - | - | Warrant | |
| ClearSign Tech Corp | Gil Todd Silva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2025 | 26,830 | 120,469 | - | - | Restricted Stock Units | |
| Cingulate Inc | Raul R. Silva | EVP and CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2025 | 7,334 | 7,334 | - | - | Stock Option (right to Buy) | |
| LB Pharmaceuticals Inc | Richard Anthony Silva | SVP, Technical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2025 | 80,899 | 80,899 | - | - | Employee Stock Option (Right to Buy) | |
| LB Pharmaceuticals Inc | Richard Anthony Silva | SVP, Technical Operations | Sale or transfer of securities back to the company at price $ 0.00 per share. | 10 Sep 2025 | 8,964 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| LB Pharmaceuticals Inc | Richard Anthony Silva | SVP, Technical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2025 | 8,964 | 8,964 | - | - | Employee Stock Option (Right to Buy) | |
| Community West Bancshares. | Dorothea D. Silva | Director | Purchase of securities on an exchange or from another person at price $ 21.29 per share. | 29 Aug 2025 | 17 | 12,144 (0%) | 0% | 21.3 | 362 | CWBC - Common Stock |
| Fresh Del Monte Produce Inc | Effie D. Silva | SVP, General Counsel & Secy | Sale of securities on an exchange or to another person at price $ 37.54 per share. | 04 Aug 2025 | 1,315 | 7,377 (0%) | 0% | 37.5 | 49,365 | Ordinary Shares |
| Cingulate Inc | Raul R. Silva | EVP and CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2025 | 51,500 | 51,500 | - | - | Stock Option (right to Buy) | |
| Jupiter Neurosciences Inc | Alison D. Silva | Pres + Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2025 | 255,320 | 255,320 | - | - | Stock Option (right to buy) | |
| ClearSign Tech Corp | Gil Todd Silva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 32,638 | 93,639 | - | - | Restricted Stock Units | |
| Jupiter Neurosciences Inc | Alison D. Silva | Director, Pres + Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 1.04 per share. | 01 Jul 2025 | 250 | 112,777 | - | 1.0 | 259 | Common Stock |
| Jupiter Neurosciences Inc | Alison D. Silva | Director, Pres + Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 1.03 per share. | 01 Jul 2025 | 250 | 112,527 | - | 1.0 | 257 | Common Stock |
| Jupiter Neurosciences Inc | Alison D. Silva | Director, Pres + Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 1.03 per share. | 01 Jul 2025 | 250 | 112,277 | - | 1.0 | 257 | Common Stock |
| Cencora | Silvana Battaglia | Executive Vice President | Grant, award, or other acquisition of securities at price $ 257.69 per share. | 30 Jun 2025 | 52 | 11,349 (0%) | 0% | 257.7 | 13,400 | Common Stock |
| Cencora | Silvana Battaglia | Executive Vice President | Sale of securities on an exchange or to another person at price $ 297.40 per share. | 18 Jun 2025 | 4,077 | 11,296 (0%) | 0% | 297.4 | 1,212,520 | Common Stock |
| Rapport Therapeutics Inc | Paul M. Silva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 10,925 | 10,925 | - | - | Stock Option (Right to Buy) | |
| Jupiter Neurosciences Inc | Alison D. Silva | Director, Pres + Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2025 | 110,227 | 110,227 | - | 0 | Common Stock | |
| Jupiter Neurosciences Inc | Alison D. Silva | Director, Pres + Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 1.02 per share. | 02 Jun 2025 | 250 | 111 | - | 1.0 | 255 | Common Stock |
| Jupiter Neurosciences Inc | Alison D. Silva | Director, Pres + Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 1.04 per share. | 02 Jun 2025 | 250 | 111,927 | - | 1.0 | 259 | Common Stock |
| Jupiter Neurosciences Inc | Alison D. Silva | Director, Pres + Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 1.03 per share. | 02 Jun 2025 | 250 | 111,677 | - | 1.0 | 258 | Common Stock |
| Jupiter Neurosciences Inc | Alison D. Silva | Director, Pres + Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 1.00 per share. | 02 Jun 2025 | 250 | 110,477 | - | 1 | 250 | Common Stock |
| Jupiter Neurosciences Inc | Alison D. Silva | Director, Pres + Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 1.04 per share. | 02 Jun 2025 | 250 | 110,827 | - | 1.0 | 261 | Common Stock |
| Jupiter Neurosciences Inc | Alison D. Silva | Director, Pres + Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 1.05 per share. | 02 Jun 2025 | 250 | 111,077 | - | 1.1 | 263 | Common Stock |
| Jupiter Neurosciences Inc | Alison D. Silva | Director, Pres + Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 1.05 per share. | 02 Jun 2025 | 100 | 112,027 | - | 1.1 | 105 | Common Stock |
| Jupiter Neurosciences Inc | Alison D. Silva | Director, Pres + Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 1.04 per share. | 02 Jun 2025 | 100 | 110,577 | - | 1.0 | 104 | Common Stock |
| Jupiter Neurosciences Inc | Alison D. Silva | Director, Pres + Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 1.02 per share. | 02 Jun 2025 | 100 | 111,177 | - | 1.0 | 102 | Common Stock |
| Agilon Health Inc | Silvana Battaglia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2025 | 78,724 | 144,868 | - | 0 | Common Stock | |
| Nurix Therapeutics Inc | Paul M. Silva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 25,000 | 25,000 | - | - | Director Stock Option (right to buy) | |
| Community West Bancshares. | Dorothea D. Silva | Director | Purchase of securities on an exchange or from another person at price $ 18.85 per share. | 09 May 2025 | 84 | 12,127 (0%) | 0% | 18.8 | 1,583 | CWBC - Common Stock |
| Anywhere Real Estate Inc | Enrique Silva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2025 | 43,127 | 186,778 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Community West Bancshares. | Dorothea D. Silva | Director | Grant, award, or other acquisition of securities at price $ 17.60 per share. | 07 May 2025 | 1,819 | 12,043 (0%) | 0% | 17.6 | 32,014 | CWBC - Common Stock |
| ACI Worldwide Inc | Alessandro da Silva | Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2025 | 13,956 | 82,230 (0%) | 0% | 0 | Common Stock | |
| ACI Worldwide Inc | Alessandro da Silva | Chief Revenue Officer | Sale or transfer of securities back to the company at price $ 52.22 per share. | 15 Apr 2025 | 6,740 | 75,490 (0%) | 0% | 52.2 | 351,963 | Common Stock |
| ClearSign Tech Corp | Gil Todd Silva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 19,369 | 61,001 | - | - | Restricted Stock Units | |
| Cingulate Inc | Raul R. Silva | EVP and CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 1,000 | 1,000 | - | - | Stock Option (right to Buy) | |
| Cingulate Inc | Raul R. Silva | EVP and CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 1,000 | 1,000 | - | - | Stock Option (right to Buy) | |
| Community West Bancshares. | Dorothea D. Silva | Director | Purchase of securities on an exchange or from another person at price $ 18.50 per share. | 19 Mar 2025 | 56 | 10,224 (0%) | 0% | 18.5 | 1,036 | CWBC - Common Stock |
| ACI Worldwide Inc | Alessandro da Silva | Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 13,966 | 69,215 (0%) | 0% | 0 | Common Stock | |
| ACI Worldwide Inc | Alessandro da Silva | Chief Revenue Officer | Sale or transfer of securities back to the company at price $ 53.70 per share. | 04 Mar 2025 | 941 | 68,274 (0%) | 0% | 53.7 | 50,532 | Common Stock |
| Fresh Del Monte Produce Inc | Effie D. Silva | SVP, General Counsel & Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 6,328 | 6,328 | - | - | Restricted Stock Units |